Conference Speakers
Christa Pawlowski PhD
Co-Founder, Chief Operating Officer, Haima Therapeutics
Dr. Christa Pawlowski has over 15 years of drug discovery and development experience across therapeutic indications including cardiovascular disorders, inflammatory diseases, immunology, and oncology. Dr. Pawlowski is COO and EVP of R&D at Haima Therapeutics, a company focused on the development of platelet-inspired nanotechnologies for the treatment of hemorrhage and other blood-related ailments. She previously served as Director of Operations at BioMotiv, a biotech accelerator, managing two start-ups: SapVax (developing immunotherapies for cancer) and Allinaire Therapeutics (developing biologics for cardiopulmonary diseases; partnered with Chiesi Farmaceutici S.p.A. in 2022). She received her PhD in Biomedical Engineering from Case Western Reserve University.
